Plasma CRP level predicts left ventricular function and exercise capacity in patients with acute myocardial

S Pandian1, V Amuthan, P Sukumar

  • 1Department of Cardiology, Madurai Medical College and Government Rajaji Hospital, Madurai.

Indian Heart Journal
|April 28, 2005
PubMed

Insights

High C-reactive protein levels after myocardial infarction indicate poorer outcomes. Elevated C-reactive protein correlates with reduced ejection fraction and exercise capacity, signaling worse prognosis in heart attack patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Medicine

Background:

  • C-reactive protein (CRP) is a key inflammatory marker.
  • Elevated CRP levels post-acute myocardial infarction (AMI) are linked to adverse clinical outcomes.
  • Predicting prognosis in AMI patients is crucial for timely intervention.

Purpose of the Study:

  • To investigate the correlation between C-reactive protein levels and left ventricular function in ST-elevation myocardial infarction (STEMI) patients.
  • To assess the relationship between CRP levels and exercise capacity post-MI.
  • To determine if CRP can serve as a prognostic marker for STEMI patients.

Main Methods:

  • One hundred STEMI patients were studied in the intensive coronary care unit.
  • Plasma CRP levels were measured upon admission using immunoturbidity.
  • Ejection fraction was assessed via echocardiography, and exercise capacity was evaluated using symptom-limited treadmill tests.

Main Results:

  • Patients with high CRP levels (6.52 +/- 3.97 mg/dl) exhibited significantly lower ejection fraction (46.7 +/- 11.9%) compared to those with low CRP (1.26 +/- 0.91 mg/dl, 56.9 +/- 7.7%).
  • Exercise capacity, measured in METs, was markedly reduced in the high CRP group (2.8 +/- 1.4 METs) versus the low CRP group (5.5 +/- 2.5 METs).
  • A statistically significant difference was observed in both ejection fraction (p=0.011) and exercise capacity (p=0.027) between the two CRP groups.

Conclusions:

  • C-reactive protein levels serve as an indicator of myocardial necrosis severity.
  • Higher CRP levels correlate with impaired left ventricular function (lower ejection fraction).
  • Elevated CRP is associated with worse prognosis and reduced exercise capacity following myocardial infarction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...